Physician

Pusadee Suchinda, MD

According to 2025 Medicare claims, Pusadee Suchinda, MD (NPI: 1194817932) practices nephrology in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is MUSC COMMUNITY PHYSICIANS (NPI: 1841878006; TIN: 853861695) and primary practice location at 29150-1900. Suchinda is affiliated with the MUSC Health Alliance, LLC (ACO ID: A5535), participating under the MSSP model.

Suchinda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 440 traditional Medicare patients, billed 24,643 HCPCS/CPT codes, and received $759,355 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,128 prescription claims across 524 beneficiaries totaling $1,896,807 in drug costs, led by Jardiance (Empagliflozin). DME data shows 135 claims. Open Payments data shows 84 records totaling $23,995. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $464,030 to $759,355. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,374,946 and ending at $1,896,807. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $42,201 to $6,162.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	806	13,199	$464,030
2016	1,098	14,335	$473,578
2017	1,126	18,990	$604,627
2018	646	13,744	$419,494
2019	562	23,344	$539,583
2020	600	63,948	$854,037
2021	588	56,767	$812,018
2022	473	40,385	$1,187,563
2023	405	43,022	$1,039,203
2024	440	24,643	$759,355

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	626	11,043	$1,374,946
2016	602	9,985	$1,885,375
2017	938	12,328	$3,734,530
2018	769	11,674	$2,584,649
2019	522	9,173	$1,584,923
2020	459	7,520	$1,499,315
2021	434	6,361	$1,161,226
2022	453	5,824	$1,416,318
2023	476	5,895	$1,833,096
2024	524	6,128	$1,896,807

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	128	592	$36,762
2016	95	486	$29,118
2017	102	409	$26,651
2018	98	424	$30,627
2019	45	418	$31,047
2020	25	364	$30,065
2021	13	366	$30,780
2022	11	304	$23,282
2023	N/R	208	$9,771
2024	N/R	135	$3,567

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	298	676	$85
80053	Blood test, comprehensive group of blood chemicals	241	503	$10
36415	Insertion of needle into vein for collection of blood sample	255	640	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	247	590	$8
82570	Creatinine level to test for kidney function or muscle injury	197	359	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	491	20,542	$397,671
Mounjaro	Tirzepatide	260	8,830	$323,814
Ozempic	Semaglutide	202	7,206	$229,704
Trulicity	Dulaglutide	147	4,888	$162,338
Velphoro	Sucroferric Oxyhydroxide	45	1,350	$91,232

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	12	$960
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	16	$788
J7520	Sirolimus, oral, 1 mg	N	N/R	12	$495
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	28	$376
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	27	$339

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	82	$1,795	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$22,200	Boehringer Ingelheim International GmbH
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pusadee Suchinda, MD?

Tedicare shows public-source Medicare data for Pusadee Suchinda, MD (NPI 1194817932), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pusadee Suchinda, MD have ACO affiliation data?

Pusadee Suchinda, MD is shown with ACO affiliation data for MUSC Health Alliance, LLC (MSSP, ACO ID A5535).

What billing organization is linked to Pusadee Suchinda, MD?

Pusadee Suchinda, MD is linked to MUSC COMMUNITY PHYSICIANS (billing NPI 1841878006) in the available physician profile data.

Does Pusadee Suchinda, MD have Open Payments data?

Pusadee Suchinda, MD has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.